Bergan Kdv Wealth Management, LLC Bluebird Bio, Inc. Transaction History

Bergan Kdv Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$8.96 - $16.31 $80 - $146	-9 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$18.04 - $22.09 $180 - $220	-10 Reduced 52.63%	9 $0
Q1 2021 May 11, 2021	SELL	$16.59 - $33.89 $49 - $101	-3 Reduced 13.64%	19 $1,000
Q3 2020 Nov 05, 2020	BUY	$34.44 - $43.75 $757 - $962	22 New	22 $1,000
Q2 2020 Aug 13, 2020	SELL	$27.12 - $45.97 $216 - $367	-8 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$46.96 - $61.67 $375 - $493	8 New	8 $1,000

151

64.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27.8M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Bergan Kdv Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bergan Kdv Wealth Management, LLC with notifications on news.